NIH-funded research R21 grant

Understanding how biological sex affects radiation-induced oral mucositis

Official title: Investigating the Impact of Biological Sex on the Pathophysiology of Radiation-Induced Oral Mucositis

Funded at State University of New York at Buffalo · NIH-11435474 · Data updated 2026-11-12

This grant explores why women and men experience different severity of mouth sores during head and neck cancer radiotherapy and how to tailor treatments to reduce pain and healing time.

More Oral Mucositis research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startJuly 9, 2026
Project endJuly 8, 2028
Funding year2026
Award (this year)$440,275
NIH project number1R21DE036324-01
Project IDNIH-11435474 on NIH RePORTER

Who could benefit from this research

Could help

Patients undergoing head and neck radiotherapy for cancer, with consideration for sex-based analyses.

Less likely to help

Some patients may not experience or benefit from the targeted pathways identified, as responses can be individual.

What this research studies

Oral mucositis from head and neck cancer radiotherapy can be severe and limit treatment. The project will compare male and female patients and tissues to uncover sex-specific biological pathways. It uses advanced techniques like single-cell RNA sequencing, spatial transcriptomics, and multimodal immune profiling to map how epithelial injury, immune cells, and tissue remodeling differ by sex. The goal is to identify targets for precision supportive care that minimizes suffering and improves recovery for all patients. The work will build a clearer picture of why sex influences mucositis and how to personalize care.

Why it matters

Potential benefit: If successful, patients could receive more effective, sex-tailored supportive therapies to reduce mucositis severity and speed healing during radiotherapy.

How similar studies have gone: Previous work shows sex differences in OM severity, and this study advances from basic observations to molecular-level explanations.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Kirkwood, Keith L — State University of New York at Buffalo
  • Study coordinator: Kirkwood, Keith L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.